Tinavi Medical Technologies Co Ltd (688277) — Capital Reinvestment Ratio

Latest as of September 2025: 0.04x

Tinavi Medical Technologies Co Ltd (688277) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥24.50 Million) in capital expenditures (CN¥928.31K). Check Tinavi Medical Technologies Co Ltd (688277) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.04x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥24.50 Million
CNY

Capital Expenditures

CN¥928.31K
CNY

Data as of

Sep 2025
Most recent filing

Tinavi Medical Technologies Co Ltd Capital Reinvestment Ratio (2015–2019)

This chart tracks Tinavi Medical Technologies Co Ltd's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Tinavi Medical Technologies Co Ltd.

Annual Capital Reinvestment Ratio for Tinavi Medical Technologies Co Ltd (2015–2019)

Year-by-year Capital Reinvestment Ratio for Tinavi Medical Technologies Co Ltd from 2015 to 2019. See 688277 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2019 0.98x CN¥20.53 Million CN¥20.17 Million ▼ -52.8%
2018 2.08x CN¥13.15 Million CN¥27.36 Million ▲ +89.9%
2017 1.10x CN¥5.73 Million CN¥6.28 Million ▲ +2709.1%
2015 0.04x CN¥41.82 Million CN¥1.63 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow